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Abstract
Purpose of review—The immune system plays a critical role in the development and 
modulation of atherosclerosis. New high-parameter technologies, including mass cytometry 
(CyTOF) and single-cell RNA sequencing (scRNAseq), allow for an encompassing analysis of 
immune cells. Unexplored marker combinations and transcriptomes can define new immune cell 
subsets and suggest their functions. Here, we review recent advances describing the immune cells 
in the artery wall of mice with and without atherosclerosis. We compare technologies and discuss 
limitations and advantages.
Recent findings—Both CyTOF and scRNAseq on leukocytes from digested aortae show 10–30 
immune cell subsets. Myeloid, T, B and natural killer cells were confirmed. Although cellular 
functions can be inferred from RNA-Seq data, some subsets cannot be identified based on current 
knowledge, suggesting they may be new cell types. CyTOF and scRNAseq each identified four B-
cell subsets and three macrophage subsets in the atherosclerotic aorta. Limitations include cell 
death caused by enzymatic digestion and the limited depth of the scRNAseq transcriptomes.
Summary—High-parameter methods are powerful tools for uncovering leukocyte diversity. 
CyTOF is currently more powerful at discerning leukocyte subsets in the atherosclerotic aorta, 
whereas scRNAseq provides more insight into their likely functions.
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INTRODUCTION
Heart attacks and strokes account for the majority of deaths worldwide. Most are caused by 
arterial thrombosis, a complication of ruptured or eroded atherosclerotic plaque [1]. The 
normal arterial wall contains endothelial cells, smooth muscle cells (SMCs), adventitial 
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fibroblasts and leukocytes including vascular macrophages [2], T cells and B cells [3■■,4]. 
Several arterial leukocyte lineages were discovered by immunostaining and studied by flow 
cytometry (FACS) of digested aortae of experimental animals. After onset of atherosclerosis, 
endothelial cells are activated and SMC phenotype changes [5,6], the number of leukocytes 
increases in the adventitia and a eointima forms that also contains many leukocytes. Vascular 
macrophages proliferate locally [7■], and new leukocyte subsets are recruited to the arterial 
wall from circulation, either across the luminal endothelium or from vasa vasorum. Stem 
cells have been observed in the adventitia that may give rise to both SMC and macrophages 
[8].
Immunohistochemistry uncovered the presence of myeloid, T, B and natural killer (NK) 
cells in atherosclerotic lesions. FACS allows the simultaneous use of 18 fluorochrome-
tagged antibodies and forward scatter (cell size) and side scatter (granularity), thus revealing 
more leukocyte subsets in the atherosclerotic mouse aorta. FACS-defined myeloid cells 
include three subsets of macrophages [9], neutrophils [10] and monocytes [11]. Furthermore, 
dendritic cells [3■■,12] and small numbers of plasmacytoid dendritic cells [13,14] can be 
found. Among αβ T cells, CD4 and CD8 [15] were found to be present, and a small number 
of γδ T cells [16]. FACS allows for intracellular staining of transcription factors, which 
identified Th1 [17], Th17 [18], follicular helper [19] and regulatory (Treg) [20] cells among 
CD4 T cells. Th1 cells are the predominant CD4 T-cell subset residing in the plaque [21]. 
Although Th2 cells are scarce in Apolipoprotein E-deficient (Apoe–/–) mice on the 
C57BL6/J background, possibly due to the known Th1 bias of this strain [22], single-cell 
RNA sequencing (scRNAseq) of murine aortae clearly demonstrated the presence of a Th2 
subset residing within the aorta [23■■]. In addition, natural killer T cells [24], innate 
lymphoid cells [25,26] and NK cells [24] were found in atherosclerotic aortae. Using 
Cxcr6GFP mice, a CXCR6+ CD4 T-cell subset was identified [27], which was confirmed by 
scRNAseq [28■■]. The FACS approach identified only a few cell types per study. The main 
advantage of FACS is its low cost per cell and high throughput (Table 1). A 14-marker FACS 
panel resolved 12 different aortic leukocyte populations simultaneously (Table 1 and 
[23■■]) (Fig. 1).
THE IMMUNE CELL LANDSCAPE IN ATHEROSCLEROSIS ASSESSED BY 
MASS CYTOMETRY
Mass cytometry (CyTOF) allows for the simultaneous detection of up to 42 parameters 
based on metal-conjugated monoclonal antibodies with no spectral overlap [29]. These are 
clear advantages over FACS. We recently performed CyTOF to more comprehensively and 
precisely assess the immune landscape in the Apoe–/– model of atherosclerosis [23■■,
28■■]. We applied a 35-marker CyTOF panel followed by Pheno-Graph, a dimensionality 
reduction and unsupervised clustering algorithm [30]. Of the, at least, 32 billion possible 
marker combinations, the analysis grouped aortic leukocytes into 23 clusters (Table 2), 
including four B-cell clusters, five T-cell clusters, NK cells, eosinophils, neutrophils, three 
dendritic cell clusters, two monocyte clusters, three macrophage clusters and three yet 
unknown populations with unique marker combinations. Although the frequency of 
macrophages was unsurprisingly increasing in the aorta of Apoe–/– mice fed Western diet, 
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one B-cell population and a Ly-6Chi CD8+ T-cell population both vanished [23■■]. Cole et 
al. [31■] identified 13 principal aortic immune populations in aortas of Apoe–/– mice 
including one population each of neutrophils, eosinophils, B cells, monocytes, macrophages, 
CD4+ T cells, CD8+ T cells, γδ T cells, NK cells, ILCs, plasmacytoid dendritic cells and 
two populations of dendritic cells. Subclustering of only myeloid cells uncovered 20 
different populations of which subsets of CD169+CD206+ macrophages (one expressing 
CD209b and the other not) and common dendritic cells were significantly reduced in the 
aortae of cholate-free high-fat-fed Apoe–/– mice [31■].
BEFORE SINGLE-CELL RNA SEQUENCING
Trogan et al. [32] dissected macrophage-rich areas of atherosclerotic plaques from Apoe–/– 
mice by laser-capture microdissection (LCM) and analyzed the expression of several 
macrophage-related genes by quantitative PCR. Microarray analysis of LCM-dissected 
CD68+ cells from shoulder regions of human plaques showed 72 genes, among them IRF5 
and CSF1, to be upregulated compared with in-vitro stimulated THP1 cells [33]. LCM was 
used to generate the first aortic transcript atlas of wild-type and atherosclerotic Apoe–/– mice 
[34■,35■,36]. Although not single-cell, this LCM effort yielded transcriptional profiles of 
the plaque, media, adventitia and adventitia harboring arterial tertiary lymphoid organs 
(ATLOs). LCM and microarrays also showed differences in the transcriptional landscape of 
atherosclerotic plaques obtained by carotid endarterectomy from symptomatic and 
nonsymptomatic patients [37■].
Next-generation sequencing allows for a deeper insight into the entire transcriptome without 
having to decide a priori which transcripts should be measured. This methodology was first 
used in atherosclerosis to determine the transcriptional differences of effector T cells (Teff), 
Tregs and a newly defined population of CCR5+ Teff cells appearing at later stages of 
atherosclerosis [38]. FACS-sorting the cells requires a-priori knowledge of the phenotype 
(surface markers) of the cell type to be analyzed. Thus, bulk transcriptomics is less suitable 
for discovery purposes of yet undefined cell types.
SINGLE-CELL RNA SEQUENCING
The first application of single-cell transcriptomics in atherosclerosis focused on T cells and 
described a population called Th1/Tregs [39■■], which is very similar to the aforementioned 
CCR5+ Teff cells. This group used the Fluidigm C1 single microfluidics chip device 
(Fluidigm, California, USA) for capturing and preparing libraries of 270 cells of interest 
sorted by FACS.
Microfluidic devices encapsulating single cells in solvent droplets embedded in silicone oil 
recently became commercially available (10× Genomics, Pleasanton, California, USA), 
allowing for massively parallel transcriptome assessment of single cells (Drop-Seq) [40]. 
This technology, used in two recent publications, is now robust, reproducible and 
economical [23■■,28■■]. At this time, new scRNAseq techniques are being described every 
year, and the field is not settled. There are significant differences in sensitivity, coverage, 
precision, reproducibility, cost, time and scalability [41].
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Most of the scRNAseq techniques enrich only for the 3′ ends of the transcripts; however, a 
switching mechanism at the 5′ end of the RNA template, (SMART)-Seq and its derivatives 
[42,43], produces reads spanning entire transcripts. Although the former can be suitable for 
studies exploring the heterogeneity of various tissues, only the latter can be used to study 
splicing isoforms, structural variation and single-nucleotide polymorphisms.
A known shortcoming of Drop-Seq is the random encapsulation of cells into the drops, so 
abundant cell types are sequenced more often than rare ones. Another inherent shortcoming 
is the occurrence of doublets, which can be mitigated by reducing the number of cells per 
microfluidic channel [44], but this increases the cost per cell.
IMMUNE CELL HETEROGENEITY IN ATHEROSCLEROSIS ASSESSED BY 
SINGLE-CELL RNA SEQUENCING
scRNAseq identified 11– 13 distinct immune cell populations (Table 2) based on SEURAT, 
an algorithm that provides unsupervised identification of cells based on similarity in their 
transcriptomes [45]. The Drop-Seq approach detected an average of 1004–1873 genes per 
cell, which is state of the art and accounts for about 10% of the transcriptome [23■■,28■■]. 
Increasing sequencing depth would not detect more genes, as saturation was already reached 
at 1 million reads per cell. Genomic gating by Seq-Geq (FlowJo LLC, Ashland, California, 
USA) of scRNAseq data increased the B-cell diversity from two populations to three, which 
is the same number found by mass cytometry and FACS (Table 2). A B1-like cell subset was 
enriched for tumor necrosis factor signaling and produced large amounts of CCL5, 
suggesting a functional role to recruit more immune cells to the aorta [23■■]. Furthermore, 
two B2-like subsets, both producing IFNγ and granuolcyte monocyte colony stimulating 
factor, were identified.
Macrophages are resident in almost all healthy tissues [46] including healthy mouse aortae 
[2]. The transcriptomes of FACS-sorted macrophages have been reported [47,48], but the 
two recent publications [23■■,28■■] are the first to show evidence of macrophage 
heterogeneity in atherosclerotic mouse aortae. All macrophages express the adhesion G-
protein-coupled receptor, F4/80, and most also express the Fcg receptor-1 (CD64) and the 
receptor tyrosine kinase, MerTK [48,49]. In healthy mouse aortae, only a single population 
of macrophages was found by scRNAseq [28■■], which corresponded to previously defined 
resident vascular macrophages [2]. In atherosclerotic Ldlr–/– aortae, two additional subsets 
of macrophages were uncovered, one of which uniquely expressed TREM2 and another 
resembled an inflammatory macrophage phenotype that may be specific for atherosclerosis 
[28■■]. In atherosclerotic Apoe–/– mice, CyTOF identified three macrophage subsets that 
expressed CX3CR1, CD11c and CD103, respectively (Table 2 and [23■■]). Genomic gating 
of scRNAseq data for Adgre1 (F4/80) and Cd68 revealed four macrophage subsets. It is not 
known if and how these correspond to the subsets seen in aortae of Ldlr–/– mice.
Direct comparison of the principal immune cell populations across the single-cell 
transcriptomes reveals similar proportions of NK cells and a higher abundance of T cells in 
aortae of Apoe–/– mice, whereas macrophages, although increasing upon Western diet 
feeding in both mice, are more predominant in Ldlr–/– mice (Fig. 2). Significantly, the 
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frequency of B cells is higher in Apoe–/– and Ldlr–/– mice fed chow diet compared with 
Ldlr–/– mice fed a cholesterol-rich diet. This suggests a substantial dynamic range of aortic 
immune cells across the different models. However, at this point, it is unclear whether a 
difference in digestion protocols (digest for 60 min [23■■] vs. 40 min [28■■]) might favor 
the isolation of lymphocytes or myeloid cells.
GENE SIGNATURES AS PROGNOSTIC MARKERS
Single-cell technologies, like CyTOF and scRNAseq, have provided promising advances in 
many diseases and disease models. Spitzer et al. [50] observed a multiorgan immune system 
response during cancer treatment and found that specific cell-type abundance predicted 
effective cancer therapy. Immune cell signatures before surgery predict recovery [51]. 
Activation and responsiveness states of B-cell sub-sets in the bone marrow were found to 
predict relapse in patients with B-cell precursor acute lymphoblastic leukemia [52]. Gene 
signatures from bulk transcriptomic data have shown promise as prognostic or diagnostic 
indicators of disease [53–55]. Gene expression deconvolution algorithms, such as 
CIBERSORT [56], allow for the in-silico dissection of biopsies from patients by probing the 
transcriptome of individual leukocyte signatures and estimating their respective abundance 
[57]. We extracted 11 signatures from the single-cell transcriptomes of the murine aortic 
leukocytes and tested whether these signatures had predictive value in the BiKE cohort 
[37■] (Fig. 1). The BiKE study contains bulk transcriptomes from 100 human 
atherosclerotic plaques from carotid endarterectomies. As in mouse lesions, the predominant 
signature is derived from macrophages (55%), whereas T cells, B cells and monocytes make 
up 40% of the lesional immune cells, and NK cells are the smallest population (Fig. 2). 
From all 11 single-cell transcriptomes identified in atherosclerotic mouse aortae, the 
memory T-cell population correlated negatively and significantly with ischemic event-free 
survival of the patient [23■■].
Although single-cell methods require dissection and digestion, which means cellular spatial 
information is lost, we were able to gain insight into the spatial distribution of some immune 
cell populations by genetically deconvolving the individual mouse immune cell signatures 
with bulk transcriptomes derived by LCM of murine aortae (lesion, media, adventitia and 
adventitia with ATLOs) (Fig. 2 and [23■■]). This confirmed that the majority of aortic B 
cells reside in the adventitia, whereas macrophages, T cells and monocytes populate the 
plaque (Fig. 2 and [23■■]). This approach also corrects for the under-sampling of 
macrophages caused by the digestion and mechanical disruption of the tissue.
LIMITATIONS
Although CyTOF and scRNAseq provide a wealth of information, they both share the need 
for making single-cell suspensions by enzymatic and mechanical tissue disruption. Although 
dead cells are excluded by staining in CyTOF, cell death does not affect all cells equally, and 
this distorts the proportions. Large, branched cells like macrophages are systematically 
undersampled, as they are more likely to be destroyed by the enzymatic and mechanical 
dissociation [58]. As mentioned above, this can be corrected by running the scRNAseq-
based gene signatures on bulk transcriptomes of LCM material using CIBERSORT. 
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Contamination with circulating leukocytes can be controlled by injecting an anti-CD45 
antibody to stain intravascular leukocytes and exclude them from subsequent analysis.
CyTOF is a destructive method, which means the cells analyzed cannot be recovered. 
CyTOF is currently limited by 42 lanthanide isotopes that are commercially available, but 
more metals are likely to become available soon. The most severe drawback of CyTOF is 
that it depends on user-driven selection of markers.
scRNAseq is truly hypothesis-free, but the spatial location of the interrogated cells is usually 
lost. An attempt to circumvent this limitation is the use of a photoconvertible fluorochrome 
to label a subset of immune cells in a known location before harvesting [59]. Downstream 
analysis of scRNAseq is more complex than bulk RNA sequencing due to the increased 
technical variability among individual cells, which can be attributed to the cell-cycle state 
[60], the burstiness of gene expression [61], the drop-out probability of low-expressed genes 
and the different PCR efficiency across the cells and across transcripts within the same cell. 
The lack of depth in scRNAseq transcriptomes appears to be fundamental and, in part, 
represents the fact that rare transcripts may not be in the cell at the time of harvest 
(stochastic dropouts). This can be overcome, partly, by constructing synthetic transcriptomes 
from the cells found in each t-distributed stochastic neighbor embedding cluster.
CONCLUSION
The immune system plays a crucial role in the progression and modulation of 
atherosclerosis. High-modality technologies including CyTOF and scRNAseq uncovered an 
unexpected diversity among aortic leukocytes. Furthermore, signatures constructed from 
single-cell transcriptomes can be useful to predict secondary ischemic events [23■■]. 
Although both CyTOF and scRNASeq were capable of detecting the principle immune 
subsets, an integration of single-cell protein and transcriptome information may uncover a 
potentially even larger heterogeneity among aortic immune subsets. Also, a single immune 
cell atlas of human plaques is yet missing. The information gained by these data will help to 
specifically tailor new therapeutic strategies for altering the immune response in 
atherosclerosis.
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KEY POINTS
• Mass cytometry and scRNAseq are powerful, high-parametric technologies 
for uncovering leukocyte diversity and yet unknown leukocyte populations.
• Both methodologies revealed an unexpected diversity among aortic 
leukocytes.
• scRNAseq reveals leukocyte subset signatures, which can be used to 
deconvolve bulk transcriptomes to assess the relative contribution of immune 
cells within the assessed tissue.
• Additional technological advances will provide a deeper look into the 
transcriptome, simultaneous integration of protein information and high-
throughput capacity.
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FIGURE 1. 
Proposed analysis workflow of single-cell RNA sequencing data. The prognostic value of 
gene signature requires data sets including patient follow-up information.
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FIGURE 2. 
Relative presence of principal immune populations (NK cells, macrophages, B cells, 
monocytes, T cells) in the aortae of Apoe–/– and Ldlr–/– identified by single-cell RNA 
sequencing [23■■,28■■]. Bulk transcriptomes derived by laser capture microdissection 
from lesion, media, adventitia, and adventitia with artery tertiary lymphoid organ from 78-
week old Apoe–/– mice (GSE21419) were genetically deconvolved with the single-cell 
transcriptome signatures of the principal immune cell populations in the aorta of Apoe–/– 
mice [23■■]. Similarly, bulk transcriptomes of 126 human lesions obtained by carotid 
endarterectomy were genetically deconvolved with the same single-cell transcriptome 
signatures [23■■].
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